These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8252767)

  • 41. [Report of a case of malignant atrophic papulosis or Degos disease].
    De Leo G; Losacco T; Punzo C; Lavacca M; Pitzalis MV; De Tommaso C; Posca A
    G Chir; 1994 Mar; 15(3):97-102. PubMed ID: 8060787
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Systemic lupus erythematosus, following prodromal idiopathic thrombocytopenic purpura, presenting with skin lesions resembling malignant atrophic papulosis.
    Wallace MP; Thomas JM; Meligonis G; Ha T
    Clin Exp Dermatol; 2017 Oct; 42(7):774-776. PubMed ID: 28691162
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Malignant atrophic papulosis (Degros disease). A report of two cases with clinical and histological studies.
    Muller SA; Landry M
    Arch Dermatol; 1976 Mar; 112(3):357-63. PubMed ID: 1259448
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of dermal blood vessels in the pathogenesis of malignant atrophic papulosis (Degos' disease). A study of two cases using enzyme histochemical, fibrinolytic, electron-microscopical and immunological techniques.
    Black MM; Nishioka K; Levene GM
    Br J Dermatol; 1973 Mar; 88(3):213-9. PubMed ID: 4351422
    [No Abstract]   [Full Text] [Related]  

  • 45. Benign atrophic papulosis (Köhlmeier-Degos disease): the wedge-shaped dermal necrosis can resolve with time.
    Zouboulis CC; Theodoridis A; Brunner M; Magro CM
    J Eur Acad Dermatol Venereol; 2017 Oct; 31(10):1753-1756. PubMed ID: 28544089
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Köhlmeier-Degos's disease with primary intestinal manifestation.
    Fruhwirth J; Mischinger HJ; Werkgartner G; Beham A; Pfaffenthaller EC
    Scand J Gastroenterol; 1997 Oct; 32(10):1066-70. PubMed ID: 9361182
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential effects of reconstituted high-density lipoprotein on coagulation, fibrinolysis and platelet activation during human endotoxemia.
    Pajkrt D; Lerch PG; van der Poll T; Levi M; Illi M; Doran JE; Arnet B; van den Ende A; ten Cate JW; van Deventer SJ
    Thromb Haemost; 1997 Feb; 77(2):303-7. PubMed ID: 9157586
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The influence of the haemodialysis procedure on platelets, coagulation and fibrinolysis.
    Sabovic M; Salobir B; Preloznik Zupan I; Bratina P; Bojec V; Buturovic Ponikvar J
    Pathophysiol Haemost Thromb; 2005; 34(6):274-8. PubMed ID: 16772739
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Decreased fibrinolytic activity and increased platelet function in hypertension. Possible influence of calcium antagonism.
    Gleerup G; Winther K
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):168S-171S. PubMed ID: 1827012
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Platelet function and fibrinolytic activity in hypertension: differential effects of calcium antagonists and beta-adrenergic receptor blockers.
    Winther K; Gleerup G; Hedner T
    J Cardiovasc Pharmacol; 1991; 18 Suppl 9():S41-4. PubMed ID: 1725542
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fibrinolytic activity and platelet release reaction in essential hypertension.
    Keskin A; Tombuloglu M; Büyükkeçeci F
    Jpn Heart J; 1994 Nov; 35(6):757-63. PubMed ID: 7897822
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Malignant atrophic papulosis.
    Scheinfeld N
    Clin Exp Dermatol; 2007 Sep; 32(5):483-7. PubMed ID: 17692056
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Occlusive Nonvasculitic Vasculopathy.
    Llamas-Velasco M; Alegría V; Santos-Briz Á; Cerroni L; Kutzner H; Requena L
    Am J Dermatopathol; 2017 Sep; 39(9):637-662. PubMed ID: 27759698
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Changes in parameters of the coagulation-fibrinolysis system and platelet function after OKY-046 administration to patients with ruptured aneurysm of the cerebral artery.
    Kosugi T; Nakamura M; Saitoh S; Noguchi S; Shimoji T; Minei S
    Int J Tissue React; 1991; 13(1):51-7. PubMed ID: 1909691
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effects of green pit viper (Trimeresurus albolabris and Trimeresurus macrops) venom on the fibrinolytic system in human.
    Rojnuckarin P; Intragumtornchai T; Sattapiboon R; Muanpasitporn C; Pakmanee N; Khow O; Swasdikul D
    Toxicon; 1999 May; 37(5):743-55. PubMed ID: 10219986
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preserved endothelial vasomotion and fibrinolytic function in patients with acute stent thrombosis or in-stent restenosis.
    Chia S; Megson IL; Ludlam CA; Fox KA; Newby DE
    Thromb Res; 2003; 111(6):343-9. PubMed ID: 14698651
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impaired fibrinolytic activity induced by ingestion of butter: effect of increased plasma lipids on the fibrinolytic activity.
    Kozima Y; Urano T; Serizawa K; Takada Y; Takada A
    Thromb Res; 1993 Apr; 70(2):191-202. PubMed ID: 8322287
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Haemostatic derangement in advanced peripheral occlusive arterial disease.
    Koksch M; Zeiger F; Wittig K; Pfeiffer D; Ruehlmann C
    Int Angiol; 1999 Dec; 18(4):256-62. PubMed ID: 10811512
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lack of correlation between blood fibrinolysis and the immediate or post-operative blood loss in transurethral resection of the prostate.
    Nielsen JD; Gram J; Fabrin K; Holm-Nielsen A; Jespersen J
    Br J Urol; 1997 Jul; 80(1):105-10. PubMed ID: 9240188
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Does calcium channel blockade and beta-adrenergic blockade affect platelet function and fibrinolysis to a varying degree?
    Gleerup G; Mehlsen J; Winther K
    J Cardiovasc Pharmacol; 1995 Jan; 25(1):87-9. PubMed ID: 7723358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.